Abstract
The present review after providing a short overview on PPARs and their pleiotropic action focuses on the QSAR studies reported mainly for PPAR-γ agonists. The different 3D and 2D QSAR models are discussed, their impact in better understanding of the mechanism of action is analyzed and their contribution in the design of new molecules is outlined.
Keywords: PPAR-γ, type II Diabetes, mechanism of action, 3D-QSAR, 2D-QSAR, drug design
Mini-Reviews in Medicinal Chemistry
Title: Structural Basis for the Design of PPAR-γ Ligands: A Survey on Quantitative Structure- Activity Relationships
Volume: 9 Issue: 9
Author(s): Costas Giaginis, Stamatios Theocharis and Anna Tsantili-Kakoulidou
Affiliation:
Keywords: PPAR-γ, type II Diabetes, mechanism of action, 3D-QSAR, 2D-QSAR, drug design
Abstract: The present review after providing a short overview on PPARs and their pleiotropic action focuses on the QSAR studies reported mainly for PPAR-γ agonists. The different 3D and 2D QSAR models are discussed, their impact in better understanding of the mechanism of action is analyzed and their contribution in the design of new molecules is outlined.
Export Options
About this article
Cite this article as:
Giaginis Costas, Theocharis Stamatios and Tsantili-Kakoulidou Anna, Structural Basis for the Design of PPAR-γ Ligands: A Survey on Quantitative Structure- Activity Relationships, Mini-Reviews in Medicinal Chemistry 2009; 9 (9) . https://dx.doi.org/10.2174/138955709788922601
DOI https://dx.doi.org/10.2174/138955709788922601 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurodegeneration and Neurogenesis: Focus on Alzheimers Disease
Current Alzheimer Research Liver Growth Factor as a Tissue Regenerating Factor in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations
Current Drug Targets A Validated UPLC Method Used for the Determination of Trandolapril and its Degradation Products as per ICH Guidelines
Current Pharmaceutical Analysis Inotropic and Vasoactive Drugs in Pediatric ICU
Current Drug Targets Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology Retraction Note: Phytochemicals from Plants to Combat Cardiovascular Disease
Current Medicinal Chemistry Current Genomics in Cardiovascular Medicine
Current Genomics Atherosclerotic Process in Seroreverter Children and Adolescents Exposed to Fetal Antiretroviral Therapy
Current HIV Research Quantitative Analysis in Cardiovascular Imaging: Current Status
Current Medical Imaging NMDA Pathology and Treatment of Schizophrenia
Current Pharmaceutical Design A Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases
Recent Patents on Cardiovascular Drug Discovery Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?
Current Cardiology Reviews Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design Restoration of Cardiomyocyte Function in Streptozotocin-Induced Diabetic Rats after Treatment with Vanadate in a Tea Decoction
Current Pharmaceutical Biotechnology The Potential Role of Antioxidants in Metabolic Syndrome
Current Pharmaceutical Design Mechanisms and Medical Management of Exercise Intolerance in Hypertrophic Cardiomyopathy
Current Pharmaceutical Design Therapeutic Targets for Heart Failure: Beyond Beta-Adrenergic and Renin-Angiotensin System Blockade
Recent Patents on Cardiovascular Drug Discovery